Showing results (391-400 of 422) with videos related to

Sort By:
Pageof 43
Heart (British Cardiac Society)|February 3, 2022
Inter-racial differences in patients undergoing transcatheter aortic valve implantationDo-Yoon Kang, Jung-Min Ahn, Juyong Brian Kim, et al.
JACC. Cardiovascular Interventions|November 28, 2021
Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve ReplacementHanbit Park, Jung-Min Ahn, Do-Yoon Kang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2021
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum DisorderRomain Marignier, Jeffrey L Bennett, Ho Jin Kim, et al.
Frontiers in Neurology|June 26, 2020
Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG AntibodiesJae-Won Hyun, Young Nam Kwon, Sung-Min Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspectsSara Samadzadeh, Mads Nikolaj Olesen, Martin Wirenfeldt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2026
Outcomes and disease activity during and after pregnancy in Asian women with MOGADJae-Won Hyun, De-Cai Tian, Yun Xu, et al.
Journal of Neurology|November 5, 2015
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromesMaciej Juryńczyk, Brian Weinshenker, Gulsen Akman-Demir, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 20, 2024
Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated DiseaseAna Beatriz Ayroza Galvão Ribeiro Gomes, Su-Hyun Kim, Roxanne Pretzsch, et al.
Frontiers in Immunology|July 18, 2024
Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)Sara Samadzadeh, Rafl Adnan, Paulina Berglova, et al.
Pageof 43